A Phase 3, 26-Week Randomized Controlled Study to Assess Safety and Efficacy of Tenapanor for Treatment of Chronic Idiopathic Constipation in Adults: Design and Rationale

Ibsrela (tenapanor) - Ardelyx

Susan Edelstein PhD 1; Yang Yang PhD 1; Jocelyn M. Tabora MS 1; Kenji Kozuka MS 1; Karishma Raju MBBS 1; Anthony J. Lembo MD 2

Aug 29, 2026